Safety data sheet. GHS / OSHA HCS 2012 format, 16 sections. Issued by Epic Peptides Lab for the catalogue items listed in Section 1.

Epic Peptides Lab

Safety data sheet · solution, vial

Epic Peptides Lab · USA

Document number: PL-SDS-101
Revision: 1.0 · 2026-10-03

Lipo-C Blend (methionine, inositol, choline, cyanocobalamin)

solution, vial

1Identification

Product Identifier

Document Number

PL-SDS-101

Catalogue Items Covered

Id
2263
Name
Pryma Lipo-C (FAT BLASTER)
Sku
PL-LIPOC-BLD

Recommended Use

Laboratory research use by trained personnel.

Restrictions On Use

Not for human or veterinary use.

Supplier / Distributor

Epic Peptides Lab, USA

Telephone

+1 (787) 468-5291

info@epicpeptideslab.com

2Hazard(s) identification

Classification: Not classified as hazardous under OSHA HCS 2012 (29 CFR 1910.1200) or UN GHS, on the basis of the supplier safety data sheets consulted.
Label Elements: No data available.
Signal Word: No data available.
Other Hazards: No data available.

3Composition / information on ingredients

Description

Sterile aqueous solution in a sealed multi-dose glass vial with a rubber stopper.

Composition

Name
Methionine
Full
L-Methionine
Cas
63-68-3
Formula
C5H11NO2S
Conc
as labelled (< 10% w/v)
Qty
as labelled
Name
Inositol
Full
myo-Inositol
Cas
87-89-8
Formula
C6H12O6
Conc
as labelled (< 10% w/v)
Qty
as labelled
Name
Choline
Full
Choline (as chloride or bitartrate)
Cas
67-48-1
Formula
C5H14ClNO
Conc
as labelled (< 10% w/v)
Qty
as labelled
Name
Cyanocobalamin
Full
Cyanocobalamin (vitamin B12)
Cas
68-19-9
Formula
C63H88CoN14O14P
Conc
as labelled (< 10% w/v)
Qty
as labelled
Name
Benzyl alcohol (preservative)
Full
Benzyl alcohol, antimicrobial preservative (0.9% w/v in bacteriostatic water)
Cas
100-51-6
Formula
C7H8O
Conc
0.9% w/v
Hazards
- Acute toxicity, oral — Category 4 — H302
- Acute toxicity, inhalation — Category 4 — H332
- Serious eye damage/eye irritation — Category 2A — H319
- Skin sensitisation — Category 1B — H317
Name
Water for injection
Full
Water for injection
Cas
7732-18-5
Formula
H2O
Conc
balance to 100%

4First-aid measures

First Aid Measures

Inhalation: Move the person to fresh air and keep comfortable for breathing. If breathing is difficult or symptoms persist, call a POISON CENTER or doctor.
Skin: Take off contaminated clothing. Wash the skin with plenty of soap and water. If irritation or a rash develops, get medical advice.
Eyes: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do; continue rinsing. If eye irritation persists, get medical advice.
Ingestion: Rinse mouth. Do not induce vomiting. Call a POISON CENTER or doctor if you feel unwell.
Injection: For an accidental needle-stick: wash the site with soap and water, do not squeeze, cover with a dressing and seek medical advice; report the incident according to your laboratory's sharps procedure.

Most Important Symptoms And Effects

No specific symptoms are known. Pharmacologically active material: systemic effects consistent with its mechanism of action are possible after accidental injection, ingestion or absorption.

Likely Routes Of Exposure

Skin and eye contact from splashes; accidental injection with needles used to withdraw the solution; ingestion.

5Fire-fighting measures

Fire Fighting Information: Aqueous solution; not flammable and does not support combustion.

6Accidental release measures

Spill And Clean Up Procedures: Absorb small spills with paper towel or an inert absorbent, place in a sealed container for disposal and clean the area with water and detergent.

7Handling and storage

Safe Handling: Use aseptic technique when withdrawing solution. Avoid splashes to eyes and skin. Do not pipette by mouth. Wash hands after handling.
Safe Storage: Store at 2–8 °C, protected from light; do not freeze. Keep the vial upright and tightly closed.
Storage Temperature: 2–8 °C, protected from light; do not freeze
Incompatible Materials: Spectrum: none known; Acids; alkalis

8Exposure controls / personal protection

Occupational Exposure Limits: Benzyl alcohol: no OSHA PEL, ACGIH TLV or NIOSH REL; AIHA WEEL 10 ppm (44 mg/m³) 8-h TWA. Present at 0.9%.

No occupational exposure limits have been established for the active ingredient(s).
Exposure Controls And PPE: No data available.

9Physical and chemical properties

Physical State

Liquid

Appearance

Clear red to pink aqueous solution

Properties

Odor: Odourless to faint aromatic odour (benzyl alcohol)
Ph: Approximately 4.5–7.0 (bacteriostatic water, USP) unless adjusted
Melting: About 0 °C (aqueous solution)
Boiling: About 100 °C (aqueous solution)
Flash: Not flammable; aqueous solution (benzyl alcohol flash point 93–101 °C, present at 0.9%)
Vapour: As water (about 2.3 kPa at 20 °C)
Density: About 1.00–1.02 g/mL at 20 °C
Solubility: Aqueous solution; miscible with water
Logp: -1.87 (Spectrum SDS)
Decomp: Not applicable (aqueous solution); dissolved peptide degrades on heating

10Stability and reactivity

Stability And Reactivity

Reactivity: Stable under normal temperatures and pressures (Fisher)
Incompatible: Oxidizing agents (Spectrum); strong oxidizing agents (Fisher)
Decomposition: Carbon monoxide, carbon dioxide, nitrogen oxides (NOx), sulfur oxides (Spectrum, Fisher)
Conditions To Avoid: Heat, exposure to light, dust formation (Spectrum); prolonged exposure to air (Fisher)

Conditions To Avoid

Heat, exposure to light, dust formation (Spectrum); prolonged exposure to air (Fisher); None known (Spectrum); generic: heat, dust formation; Heat; exposure to moisture/moist air (Spectrum); Light, moisture, excess heat/extreme temperatures, dust generation (Fisher, Medisca)

Incompatible Materials

Spectrum: none known; Acids; alkalis

11Toxicological information

Toxicological Information: Acute toxicity, oral
LD50 oral rat 36 g/kg (36,000 mg/kg) (Spectrum, Fisher)

Acute toxicity, dermal
No data available

Acute toxicity, inhalation
No data available

Skin corrosion/irritation
May cause skin irritation (non-classifying remark; Spectrum, Fisher)

Serious eye damage/irritation
May cause eye irritation (non-classifying remark)

Respiratory or skin sensitisation
No information available

Germ cell mutagenicity
No data available

Carcinogenicity
Not listed by IARC, ACGIH, NTP, OSHA (Spectrum, Fisher)

Reproductive toxicity
Spectrum: no data available. Fisher MSDS: 'reproductive effects observed experimentally; fetotoxicity noted with musculoskeletal abnormalities' (high-dose animal data, not classified)

STOT, single exposure
May cause respiratory tract irritation (dust, non-classifying remark)

STOT, repeated exposure
No data available

Aspiration hazard
No data available
Routes Of Exposure: Skin and eye contact from splashes; accidental injection with needles used to withdraw the solution; ingestion.
Symptoms: No specific symptoms are known. Pharmacologically active material: systemic effects consistent with its mechanism of action are possible after accidental injection, ingestion or absorption.

12Ecological information

Ecological Information: No data available for ecotoxicity, persistence, bioaccumulation or mobility (Spectrum, Fisher). Amino acid - readily biodegradable, low aquatic toxicity expected.

13Disposal considerations

Disposal Guidance: No data available.

14Transport information

Transport Classification

Note: Not regulated as a dangerous good for transport by road (DOT 49 CFR), air (IATA/ICAO) or sea (IMDG). Not a marine pollutant. Ship refrigerated or frozen as required by Section 7; the coolant (dry ice, UN 1845) is regulated when used.

15Regulatory information

Regulatory Information

Tsca: Listed, active (Spectrum: 'Present (Active)'; Fisher: listed on TSCA and Canada DSL)
Carcinogen Listings: Not listed by IARC, ACGIH, NTP, OSHA; not on California Prop 65
Dea: Not scheduled
Other: FDA direct food additive 21 CFR 172.320; GRAS as nutrient. Not WADA-listed.

Carcinogen Listings

No data available.

16Other information

Revision: October 3, 2026
Sources Consulted: Spectrum Chemical

Fisher Scientific

PhytoTech Labs

TCI

Merck Life Science / Sigma-Aldrich

ChemicalBook generic SDS for choline bitartrate

U.S. Pharmacopeia

Medisca

TOKU-E

Laboratorios Guinama

American Regent

Sigma-Aldrich
Confidence: high
Additional Information: The ratio of the lipotropic components is not standardised and is not disclosed on the product record; all components are unclassified, so the classification does not depend on it.

Back to SDS list